News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

July 2015

Top

Bristol-Myers Squibb launches Opdivo in UK for advanced melanoma
02 July 2015 Bristol-Myers Squibb (BMS) has launched Opdivo (nivolumab) in the UK as monotherapy for adult patients suffering from advanced (unresectable or metastatic) melanoma....

ViiV Healthcare and China’s Desano sign manufacturing deal for new HIV drug Tivicay
02 July 2015 Pfizer and GlaxoSmithKline (GSK) joint venture ViiV Healthcare and Shanghai-based Desano Pharmaceuticals have signed a manufacturing agreement to produce a new HIV drug Tivicay (dolutegravir...

Theravance’s Vibativ bactericidal antibiotic receives Russian approval
01 July 2015 The Russian Federation Health Ministry has granted approval to Theravance Biopharma's Vibativ (telavancin) to treat Gram-positive complicated skin and soft tissue infections....

AstraZeneca and Eolas to develop Orexin-1 receptor antagonist for addiction
01 July 2015 AstraZeneca has partnered to develop US-based Eolas Therapeutics's anti-addiction programme, Eolas Orexin-1 Receptor Antagonist (EORA)....

June 2015

Top

AMAG Pharmaceuticals to buy Cord Blood Registry for $700m
30 June 2015 US-based Specialty drug company AMAG Pharmaceuticals has agreed a $700m purchase of the world's largest newborn stem cell collection and storage company, Cord Blood Registry (CBR)....

Ablynx and Taisho to develop and commercialise anti-TNFa nanobody in Japan
30 June 2015 Belgium-based biopharmaceutical company Ablynx has entered a licence agreement with Taisho Pharmaceutical to develop and commercialise its anti-TNFa nanobody, ozoralizumab, to treat...

EU CHMP recommends Roche’s Perjeta for pre-surgery use in breast cancer
29 June 2015 The European Union (EU) Committee for Medicinal Products for Human Use (CHMP) has recommended for approval Roche's Perjeta along with Herceptin and chemotherapy for neoadjuvant treatment of...

Novartis agrees to acquire drug development firm Spinifex Pharmaceuticals
29 June 2015 Novartis has agreed to purchase a US and Australian-based privately held development stage company Spinifex Pharmaceuticals for an undisclosed amount....

UCL-led study shows cancer drugs delay ageing process in fruit flies
26 June 2015 A study led by the University College London has shown that cancer drugs such as Trametinib can delay the ageing process in adult fruit flies....

London Mayor plans to create £10bn ‘megafund’ for new drugs and therapies
26 June 2015 London Mayor Boris Johnson has announced plans to establish a £10bn 'megafund' to support UK pharmaceutical companies developing new drugs and treatments....

Siemens and BioNTech team-up for personalised cancer vaccines
25 June 2015 Siemens and BioNTech have partnered to establish a paperless, commercial-scale good manufacturing practice (GMP) production facility for personalised cancer vaccines....

Texas researchers say antihypertensive drug may stop drug and alcohol addiction
25 June 2015 Researchers at the University of Texas at Austin have revealed that an antihypertensive drug called isradipine could help stop cocaine and alcohol addiction....

IMS Health and Foundation Medicine partner to advance precision medicines for cancer
24 June 2015 IMS Health and Foundation Medicine have entered a partnership to advance the understanding and effectiveness of precision therapies to treat cancer....

Swedish researchers say impotence drugs do not cause malignant melanoma
24 June 2015 Researchers from Sweden's Umea University have revealed that the use of drugs for impotence will not raise the risk of malignant melanoma, in a collaboration with researchers in Uppsala, Lund...

Pfizer to purchase GSK’s Nimenrix and Mencevax vaccines for $130m
23 June 2015 Pfizer has signed an agreement to acquire quadrivalent meningitis ACWY vaccines Nimenrix and Mencevax from GlaxoSmithKline (GSK) for around $130m (€115m)....

Kite and bluebird to co-develop second generation TCR therapy products
23 June 2015 Kite Pharma and bluebird bio have entered a strategic collaboration agreement to develop and commercialise second-generation T-cell receptor (TCR) therapy products to treat human...

Aimmune’s AR101 receives FDA breakthrough therapy status to treat peanut allergy
22 June 2015 Aimmune Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its lead investigational product, AR101, as oral immunotherapy for...

BMS receives European approval for Opdivo to treat advanced melanoma
22 June 2015 Bristol-Myers Squibb (BMS) has received approval from the European Commission (EC) for its PD-1 immune checkpoint inhibitor, Opdivo (nivolumab), to treat advanced (unresectable or...

Eli Lilly and Dana-Farber partner to advance development of cancer drugs
19 June 2015 US-based Eli Lilly and Company has entered a multi-year collaboration agreement with Harvard Medical School principal teaching affiliate Dana-Farber Cancer Institute to advance the development...

Novartis’s Sandoz introduces generic version of Teva’s multiple sclerosis drug
19 June 2015 Novartis subsidiary Sandoz has introduced Glatopa in the US, a generic version of Teva's Copaxone (glatiramer acetate injection) 20mg/ml one-time-daily multiple sclerosis (MS) therapy....

Allergan to buy Kythera Biopharmaceuticals for $2.1bn
18 June 2015 Irish company Allergan has signed an agreement to acquire US-based Kythera Biopharmaceuticals for around $2.1bn....